AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 173 filers reported holding AXSOME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,504,000 | -54.6% | 21,515 | -53.3% | 0.00% | -50.0% |
| Q2 2023 | $3,312,000 | +169.7% | 46,091 | +131.6% | 0.00% | +300.0% |
| Q1 2023 | $1,228,000 | -13.5% | 19,904 | +8.1% | 0.00% | -50.0% |
| Q4 2022 | $1,420,000 | +14.6% | 18,406 | -33.6% | 0.00% | 0.0% |
| Q3 2022 | $1,239,000 | -5.5% | 27,707 | -19.0% | 0.00% | +100.0% |
| Q2 2022 | $1,311,000 | -19.3% | 34,227 | -12.9% | 0.00% | 0.0% |
| Q1 2022 | $1,625,000 | +63.5% | 39,274 | +49.3% | 0.00% | 0.0% |
| Q4 2021 | $994,000 | +14.9% | 26,299 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $865,000 | -48.0% | 26,245 | +6.5% | 0.00% | 0.0% |
| Q2 2021 | $1,662,000 | +35.3% | 24,637 | +13.6% | 0.00% | -50.0% |
| Q1 2021 | $1,228,000 | -20.4% | 21,691 | +14.5% | 0.00% | 0.0% |
| Q4 2020 | $1,543,000 | +1759.0% | 18,940 | +1521.6% | 0.00% | – |
| Q3 2020 | $83,000 | -13.5% | 1,168 | 0.0% | 0.00% | – |
| Q2 2020 | $96,000 | – | 1,168 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,008,508 | $82,980,000 | 48.53% |
| Fairmount Funds Management LLC | 216,098 | $17,781,000 | 7.93% |
| WMS Partners, LLC | 250,000 | $20,570,000 | 4.26% |
| RTW INVESTMENTS, LP | 1,658,316 | $136,446,000 | 3.84% |
| MORGAN JESS S & CO INC | 39,328 | $3,236,000 | 3.51% |
| RA Capital Management | 2,035,132 | $167,451,000 | 3.26% |
| Ghost Tree Capital, LLC | 100,000 | $8,228,000 | 2.17% |
| ACUTA CAPITAL PARTNERS, LLC | 90,000 | $7,405,000 | 2.14% |
| Avidity Partners Management LP | 404,900 | $33,315,000 | 2.14% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,085,836 | $89,343,000 | 1.97% |